UNC2025

Catalog No.S9662 Batch:S966201

Technical Data

Formula	C₂₈H₄₀N₆O
Molecular Weight	476.66	CAS No.	1429881-91-3
Solubility (25°C)*	In vitro	DMSO	100 mg/mL (209.79 mM)
		Ethanol	60 mg/mL (125.87 mM)
		Water	Insoluble
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description

UNC2025 is a potent and orally active dual inhibitor of FLT3 and MER with IC50 of 0.35 nM and 0.46 nM, respectively. UNC2025 also inhibits AXL, TRKA, TRKC, QIK, TYRO3, SLK, NuaK1, Kit (c-Kit) and Met (c-Met) with IC50 of 1.65 nM, 1.67 nM, 4.38 nM, 5.75 nM, 5.83 nM, 6.14 nM, 7.97 nM, 8.18 nM and 364 nM, respectively.

Targets

FLT3 ^[1] (Cell-free assay)	Mer ^[1] (Cell-free assay)	Axl ^[1] (Cell-free assay)	TrkA ^[1] (Cell-free assay)	TrkC ^[1] (Cell-free assay)	View More
0.35 nM	0.46 nM	1.65 nM	1.67 nM	4.38 nM	View More

In vitro

Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that UNC2025 has similar subnanomolar activity against Flt3, an additional important target in acute myelogenous leukemia (AML), with pharmacologically useful selectivity versus other kinases examined.^[1]

In vivo

UNC2025 is a potent and highly orally bioavailable Mer inhibitor that is capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow.^[1]

Protocol (from reference)

Cell Assay:^{^[1]}	Cell lines 697 B-ALL, A549 NSCLC, Molm-14 AML cell lines Concentrations 2 nM, 4 nM, 8 nM, 10 nM, 12 nM, 16 nM, 20 nM, 30 nM, 40 nM, 50 nM Incubation Time 1 h Method 697 Cells are treated with the indicated concentrations of UNC2025 for 1 h. Pervanadate is added to cultures for 3 min to stabilize the phosphorylated form of Mer. Mer is immunoprecipitated from cell lysates, and total MER protein and Mer phosphoprotein (p-Mer) are detected by immunoblot.
Animal Study:^{^[1]}	Animal Models NOD/SCID/gamma mice Dosages 3 mg/kg Administration Oral gavage

Cell Assay:^{^[1]}

Cell lines
697 B-ALL, A549 NSCLC, Molm-14 AML cell lines
Concentrations
2 nM, 4 nM, 8 nM, 10 nM, 12 nM, 16 nM, 20 nM, 30 nM, 40 nM, 50 nM
Incubation Time
1 h
Method
697 Cells are treated with the indicated concentrations of UNC2025 for 1 h. Pervanadate is added to cultures for 3 min to stabilize the phosphorylated form of Mer. Mer is immunoprecipitated from cell lysates, and total MER protein and Mer phosphoprotein (p-Mer) are detected by immunoblot.

Animal Study:^{^[1]}

Animal Models
NOD/SCID/gamma mice
Dosages
3 mg/kg
Administration
Oral gavage

References

[1] Weihe Zhang, et al. J Med Chem. 2014 Aug 28;57(16):7031-41.

Selleck's UNC2025 has been cited by 6 publications

Regulation of brain endothelial cell physiology by the TAM receptor tyrosine kinase Mer [ Commun Biol, 2023, 6(1):916]	PubMed: 37673933
Regulation of brain endothelial cell physiology by the TAM receptor tyrosine kinase Mer [ Commun Biol, 2023, 6(1):916]	PubMed: 37673933
The Tolerogenic Influence of Dexamethasone on Dendritic Cells Is Accompanied by the Induction of Efferocytosis, Promoted by MERTK [ Int J Mol Sci, 2023, 10.3390/ijms242115903]	PubMed: 37958886
Intranasal delivery of a small-molecule ErbB inhibitor promotes recovery from acute and late-stage CNS inflammation [ JCI Insight, 2022, 7(7)e154824]	PubMed: 35393953
Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC [ Front Immunol, 2020, 11:564133]	PubMed: 33101282
New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia [ Cell Signal, 2014, 26(1):149-61]	PubMed: 24140475

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.